Oxidative stress and endosome recycling are complementary mechanisms reorganizing the T-cell receptor signaling complex in SLE

Clinical Immunology

Volumn 142, Issue 3, 2012, Pages 219-222

  Perl, Andras ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; CALCIUM CHANNEL; GLUTATHIONE; MAMMALIAN TARGET OF RAPAMYCIN; NITRIC OXIDE; PROTEIN KINASE SYK; T LYMPHOCYTE RECEPTOR; TRANSFERRIN RECEPTOR;

ANTIBODY PRODUCTION; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; EDITORIAL; ENDOPLASMIC RETICULUM; ENDOSOME; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; MACROPHAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MEMBRANE MICRODOMAINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84857357741     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.12.011     Document Type: Editorial

References (24)

1. Perl A., Fernandez D.R., Telarico T., Doherty E., Francis L., Phillips P.E. T-cell and B-cell signaling biomarkers and treatment targets in lupus. Curr. Opin. Rheumatol. 2009, 21(5):454-464.
2. Gergely P.J., Grossman C., Niland B., et al. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 2002, 46:175-190.
3. Fernandez D.R., Perl A. mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?. Discov. Med. 2010, 9(46):173-178.
4. Nambiar M.P., Fisher C.U., Warke V.G., et al. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Arthritis Rheum. 2003, 48:1948-1955.
5. Kyttaris V.C., Krishnan S., Tsokos G.C. Systems biology in systemic lupus erythematosus: Integrating genes, biology and immune function. Autoimmunity 2006, 39(8):705-709.
6. Smith-Garvin J.E., Koretzky G.A., Jordan M.S. T Cell Activation. Annu. Rev. Immunol. 2009, 27(1):591-619.
7. Koretzky G.A., Boerth N.J. The role of adapter proteins in T cell activation. Cell Mol Life Sci 1999, 56:1048-1060. [Review] [137 refs].
8. Vassilopoulos D., Kovacs B., Tsokos G.C. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. J. Immunol. 1995, 155(4):2269-2281.
9. Enyedy E.J., Nambiar M.P., Liossis S.N., Dennis G., Kammer G.M., Tsokos G.C. Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus. Arthritis Rheum. 2001, 44:1114-1121.
10. Juang Y.T., Wang Y., Jiang G., et al. PP2A Dephosphorylates Elf-1 and Determines the Expression of CD3{zeta} and FcR{gamma} in Human Systemic Lupus Erythematosus T Cells. J. Immunol. 2008, 181(5):3658-3664.
11. Chowdhury B., Tsokos C.G., Krishnan S., et al. Decreased Stability and Translation of T Cell Receptor zeta mRNA with an Alternatively Spliced 3'-Untranslated Region Contribute to zeta Chain Down-regulation in Patients with Systemic Lupus Erythematosus. J. Biol. Chem. 2005, 280(19):18959-18966.
12. Fernandez D.R., Telarico T., Bonilla E., et al. Activation of mTOR controls the loss of TCR in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J. Immunol. 2009, 182:2063-2073.
13. Nagy G., Barcza M., Gonchoroff N., Phillips P.E., Perl A. Nitric Oxide-Dependent Mitochondrial Biogenesis Generates Ca2+ Signaling Profile of Lupus T Cells. J. Immunol. 2004, 173(6):3676-3683.
14. Abdoel N., Brun S., Bracho C., Rodríguez M.A., Blasini A.M. Linker for activation of T cells is displaced from lipid rafts and decreases in lupus T cells after activation via the TCR/CD3 pathway. Clin. Immunol. 2012, 142:243-251.
15. Jury E.C., Kabouridis P.S., Abba A., Mageed R.A., Isenberg D.A. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum. 2003, 48:1343-1354.
16. Krishnan S., Juang Y.T., Chowdhury B., et al. Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells. J. Immunol. 2008, 181(11):8145-8152.
17. Kabouridis P.S., Isenberg D.A., Jury E.C. A negatively charged domain of LAT mediates its interaction with the active form of Lck. Mol. Membr. Biol. 2011, 28(7-8):487-494.
18. Ghosh D., Tsokos G.C. Spleen tyrosine kinase (Syk): a src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory disease. Autoimmunity 2010, 43:48-55.
19. Brignatz C., Restouin A., Bonello G., Olive D., Collette Y. Evidences for ubiquitination and intracellular trafficking of LAT, the linker of activated T cells. Biochim. Biophys. Acta 2005, 1746(2):108-115.
20. Nagy G., Ward J., Mosser D.D., et al. Regulation of CD4 Expression via Recycling by HRES-1/RAB4 Controls Susceptibility to HIV Infection. J. Biol. Chem. 2006, 281:34574-34591.
21. Cho C.S., Chang Z., Elkahwaji J., et al. Rapamycin antagonizes cyclosporin A and tacrolimus (FK506) mediated augmentation of linker for activation of T cell expression in T cells. Int. Immunol. 2003, 15(11):1369-1378.
22. Perl A., Gergely P., Nagy G., Koncz A., Banki K. Mitochondrial hyperpolarization: a checkpoint of T cell life, death, and autoimmunity. Trends Immunol. 2004, 25:360-367.
23. Fernandez D., Perl A. Metabolic control of T cell activation and death in SLE. Autoimmun. Rev. 2009, 8:184-189.
24. Gringhuis S.I., Papendrecht-van der Voort E., Leow A., Levarht E.W.N., Breedveld F.C., Verweij C.L. Effect of Redox Balance Alterations on Cellular Localization of LAT and Downstream T-Cell Receptor Signaling Pathways. Mol. Cell. Biol. 2002, 22(2):400-411.